Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by Davis A Brian, Chief Financial Officer. Director active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 1 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €41k. History available since 4 June 2021. The latest transaction was filed on 4 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Brian A. Davis is the Chief Financial Officer at Verrica Pharmaceuticals Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. Davis plays a crucial role in financial strategy.